US$ 22.84
tirzepatide gip analog Bumps and humps in the success of as the first GLP1 and receptor agonist Tirzepatide 10mg — GLP-1/GIP Dual-Agonist
Description
Please consult your healthcare provider about FDA-approved alternatives like Mounjaro for type 2 diabetes and Zepbound for weight loss

Not for human or veterinary use of any kind

Consuming a balanced meal that includes healthy fats, proteins, and carbohydrates may enhance the medication's absorption and effectiveness

This dual action enhances insulin secretion, slows stomach emptying, and reduces appetite through two complementary routes, leading to stronger A1C reductions and weight loss in clinical trials compared to single-pathway therapies

Side Effects Reported with Compounded Tirzepatide and with Mounjaro Reported adverse reactions tied to compounded tirzepatide include: Nausea Vomiting Diarrhea Abdominal pain Constipation Some cases required medical attention

Tracking your response to 50 units over time Documentation transforms guesswork into data
